Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human CRYM Antikörper:
anti-Mouse (Murine) CRYM Antikörper:
anti-Rat (Rattus) CRYM Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Mouse (Murine) Polyclonal CRYM Primary Antibody für WB - ABIN1881230
Al-Kafaji, Malik: Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells. in Biochemical and biophysical research communications 2010
Show all 4 Pubmed References
Human Monoclonal CRYM Primary Antibody für IHC (p), IP - ABIN560481
Reed, Corse, Porter, Flanigan, Bloch: Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. in Experimental neurology 2007
Show all 3 Pubmed References
These findings confirm that, mechanistically, ketimine reductase/CRYM acts as a classical imine reductase and may explain the finding of bound pyruvate in the crystallized protein.
ketimine reductase is a key enzyme in the pipecolate pathway, which is the main lysine degradation pathway in the brain
The expression of mu-crystallin was regulated through the AP-1 (zeige FOSB Antikörper) site in the promoter.
Its ketimine reductase activity is strongly inhibited by thyroid hormones.
This is the first report linking hyperglycemia with thyroid hormone (zeige PTH Antikörper) binding protein CRYM and suggests that the role of CRYM in diabetic complications should be further investigated.
Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues
CRYM is a novel androgen-regulated gene whose expression is elevated in prostate cancer but down-regulated in castration therapy-resistant tumors.
The results demonstrated that Crym is a crucial regulator of muscle plasticity, controlling metabolic and contractile properties of myofibers, and thus the selective inactivation of Crym may be a potential therapeutic target for muscle-wasting diseases.
Reduction of Crym expression in Huntington's disease (HD) could render striatal neurons more susceptible to mutant huntingtin (zeige HTT Antikörper) suggesting that Crym may be a key determinant of the vulnerability of the striatum.
CRYM expression increases and sustains the T3 responsiveness of genes in cells, especially with alteration of the pericellular T3 concentration.
Comparison of the apo and NADPH forms reveals a rearrangement of the protein upon NADPH binding that reduces the degrees of freedom of several residues and traps the conformation of the binding pocket in a more T3 competent state.
The expression of mu-crystallin was regulated through the AP-1 (zeige JUN Antikörper) site in the promoter.
CRYM plays an important role in the development of the second peak of murine EIU.
Disruption of the CRYM gene decreases T(3) concentrations in tissues and serum without alteration of peripheral T(3) action in vivo.
Crystallins are separated into two classes and ubiquitous. The former class is also called phylogenetically-restricted crystallins. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. This gene encodes a taxon-specific crystallin protein that binds NADPH and has sequence similarity to bacterial ornithine cyclodeaminases. The encoded protein does not perform a structural role in lens tissue, and instead it binds thyroid hormone for possible regulatory or developmental roles. Mutations in this gene have been associated with autosomal dominant non-syndromic deafness. Multiple alternatively spliced transcript variants have been found for this gene.
, mu-crystallin homolog
, mu-crystallin homolog-like
, mu-crystallin-like protein
, NADP-regulated thyroid-hormone binding protein
, ketimine reductase
, thiomorpholine-carboxylate dehydrogenase
, NADP-regulated thyroid-hormone-binding protein